Tag: alopecia areata

Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata

June 26, 2023

Via: PMLiVE

Affecting almost seven million people in the US and approximately 147 million people globally, alopecia areata is an autoimmune disease characterised by patchy or complete hair loss on the scalp, face, or body. The condition can develop at any age, […]

FDA, Regulations

FDA approves first systemic treatment for alopecia areata

June 13, 2022

Via: World Pharma News

Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year. Today’s […]

Tag: alopecia areata

Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata

FDA approves first systemic treatment for alopecia areata

Latest Publications

Input on Biosimilar Product Development Guidance Documents Sought by FDA

Third Arc’s $165m for T cell engagers, plus other bio rounds

Quality Considerations for Using AI in Bio/Pharma

Tag: alopecia areata

Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata

FDA approves first systemic treatment for alopecia areata

Trending

Tags

Latest Publications

Input on Biosimilar Product Development Guidance Documents Sought by FDA

Third Arc’s $165m for T cell engagers, plus other bio rounds

Quality Considerations for Using AI in Bio/Pharma